Wells Fargo’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-7,194
| Closed | -$72.2K | – | 7221 |
|
|
2023
Q4 | $72.2K | Buy |
7,194
+440
| +7% | +$4.42K | ﹤0.01% | 4689 |
|
|
2023
Q3 | $19.5K | Sell |
6,754
-3,455
| -34% | -$9.95K | ﹤0.01% | 5246 |
|
|
2023
Q2 | $38.9K | Buy |
10,209
+5,685
| +126% | +$21.7K | ﹤0.01% | 5232 |
|
|
2023
Q1 | $8.42K | Buy |
4,524
+894
| +25% | +$1.66K | ﹤0.01% | 5595 |
|
|
2022
Q4 | $8.35K | Sell |
3,630
-1,000
| -22% | -$2.3K | ﹤0.01% | 5296 |
|
|
2022
Q3 | $15K | Sell |
4,630
-510
| -10% | -$1.65K | ﹤0.01% | 5207 |
|
|
2022
Q2 | $28K | Sell |
5,140
-4,400
| -46% | -$24K | ﹤0.01% | 5007 |
|
|
2022
Q1 | $22K | Buy |
9,540
+3,630
| +61% | +$8.37K | ﹤0.01% | 5642 |
|
|
2021
Q4 | $36K | Sell |
5,910
-7,554
| -56% | -$46K | ﹤0.01% | 5651 |
|
|
2021
Q3 | $187K | Buy |
13,464
+13,454
| +134,540% | +$187K | ﹤0.01% | 4840 |
|
|
2021
Q2 | $0 | Sell |
10
-7,702
| -100% | – | ﹤0.01% | 7205 |
|
|
2021
Q1 | $119K | Buy |
+7,712
| New | +$119K | ﹤0.01% | 5076 |
|